J Korean Med Sci.  2023 Dec;38(50):e419. 10.3346/jkms.2023.38.e419.

Significant Gap Between Guidelines and Practice in the Management of LDL Cholesterol: Insight From the Survey of the Korean Society of Myocardial Infarction

• Lee SY
• Cho KH
• Lee JH
• Hong YJ
• Hwang Jy
• Jeong MH
• Kim W

• KMID: 2549960
• DOI: http://doi.org/10.3346/jkms.2023.38.e419

Abstract

The Guidelines of the 2019 European Society of Cardiology (ESC) and the 5th Society of Lipid and Atherosclerosis (KSoLA) for the Management of Dyslipidemia advocate a more intensive lipid-lowering strategy. However, there is a lack of evidence regarding the current status of lipid management in Korean patients in real-world practice. The Korean Society of Myocardial Infarction conducted a survey among its members of the Korean Society of Cardiology on the new lipid guidelines. Although most participants were aware of the changes in the ESC and the KSoLA guidelines, more than half of them did not agree with lowering the low-density lipoprotein cholesterol levels to < 55 mg/dL, because its safety and efficacy have not yet been proven in Koreans. A substantial disparity exists between lipid management guidelines and current clinical practices, highlighting the necessity for clinical research that specifically targets East Asians and Koreans to bridge this gap.

Keyword

Dyslipidemias; Myocardial Infarction; Cholesterol; Low-density Lipoprotein Cholesterol

Figure

• 

  Fig. 1 What is your LDL-C goal in patients with acute myocardial infarction?LDL-C = low-density lipoprotein cholesterol.

• 

  Fig. 2 Why are you not following the new goal of low-density lipoprotein cholesterol < 55 mg/dL?

Reference

1. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020; 41(1):111–188. PMID: 31504418.

2. Rhee EJ, Kim HC, Kim JH, Lee EY, Kim BJ, Kim EM, et al. 2018 Guidelines for the management of dyslipidemia. Korean J Intern Med. 2019; 34(4):723–771. PMID: 31272142.

3. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019; 139(25):e1082–e1143. PMID: 30586774.

4. Moon MK, Noh J, Rhee EJ, Park SH, Kim HC, Kim BJ, et al. Cardiovascular outcomes according to comorbidities and low-density lipoprotein cholesterol in Korean people with type 2 diabetes mellitus. Diabetes Metab J. 2023; 47(1):45–58. PMID: 36727163.

5. Lee KH, Jeong MH, Kim HM, Ahn Y, Kim JH, Chae SC, et al. Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol. J Am Coll Cardiol. 2011; 58(16):1664–1671. PMID: 21982310.

6. Nakamura M, Yamashita T, Yajima J, Oikawa Y, Ogasawara K, Sagara K, et al. Impact of early statin initiation on secondary prevention in Japanese patients with coronary artery disease. J Cardiol. 2011; 57(2):172–180. PMID: 21177073.